NEW YORK (GenomeWeb) – Mammoth Biosciences, a biotech startup cofounded by CRISPR researcher Jennifer Doudna, came out of stealth mode today by announcing a plan to develop a CRISPR-enabled platform capable of detecting any biomarker or disease containing DNA or RNA.